How much is Roivant Sciences worth in 2026?

Roivant Sciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Roivant Sciences raised?

Roivant Sciences has raised N/A in total funding across 2 funding rounds.

Roivant Sciences

Drug Discovery

Roivant Sciences valuation and funding history | Last updated: September 30, 2021 | 2 funding rounds

Current Valuation

N/A

As of September 30, 2021

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$200.0M

Last Funding

Sep 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 30, 2021	PIPE	$200.0M	N/A	-
November 13, 2018	PE Growth/Expansion	$200.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Roivant Sciences is currently valued at N/A as of September 30, 2021.

Track Roivant Sciences Valuation Updates

Get notified when Roivant Sciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Roivant Sciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Roivant Sciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Roivant Sciences Worth in 2026?

Roivant Sciences is a leading private company in the Drug Discovery sector. Track Roivant Sciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Roivant Sciences Valuation is Determined

Private company valuations like Roivant Sciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.